Author details

Skip to Main Content

Full Name

Bryan Sepulveda

Affiliation

ORCID

Career Start Year

2010

Papers

7

H Index

5

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
38086156	Effects of gene replacement therapy with resamirigene bilparvovec (AT132) on skeletal muscle pathology in X-linked myotubular myopathy: results from a substudy of the ASPIRO open-label clinical trial.	EBioMedicine	2024
34366366	Intrahepatic Cholestasis Is a Clinically Significant Feature Associated with Natural History of X-Linked Myotubular Myopathy (XLMTM): A Case Series and Biopsy Report.	J Neuromuscul Dis	2022
35694931	INCEPTUS Natural History, Run-in Study for Gene Replacement Clinical Trial in X-Linked Myotubular Myopathy.	J Neuromuscul Dis	2022
23560750	Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodies.	Biochem J	2013
23646112	Short- and long-term effects of LRRK2 on axon and dendrite growth.	PLoS ONE	2013
21335065	L1 cell adhesion molecule promotes resistance to alcohol-induced silencing of growth cone responses to guidance cues.	Neuroscience	2011
21068336	Flotillin-mediated endocytic events dictate cell type-specific responses to semaphorin 3A.	J Neurosci	2010

1 - 7 of 7

Deanna L Benson

Co-authored papers 4

Co-authored papers 3

Robert J Graham

Boston Children's Hospital

Co-authored papers 2

Stephen R Salton

Co-authored papers 2

Broad Institute of MIT and Harvard

Co-authored papers 2

Lurie Children's Hospital

Co-authored papers 2

Co-authored papers 2

Francesco Muntoni

UCL Great Ormond Street Institute of Child Health

Co-authored papers 1

Icahn School of Medicine at Mount Sinai

Co-authored papers 1

University of Dundee

Co-authored papers 1

University of Dundee

Co-authored papers 1

1 - 11